PGP and gastric cancer: In summary, our results provide strong molecular evidence in support of our hypothesis that TQ augments cisplatin-induced anti-tumor effects on gastric cancer cells via inhibiting PI3K/AKT signal pathway, activating of mitochondrial pathway, and down-regulating P-gp proteins by up-regulating PTEN gene both in vitro and vivo.